OrganiGram Releases Q3 Financial Results and Provides Operational Update

Moncton, N.B. July 30, 2015 – OrganiGram Holdings Inc. (TSX-V: OGI) (OTC US:OGRMF) (the “Company) is today releasing financial statements for the 9-month period ended May 31st, 2015.  The Company’s quarterly financial statements and Management’s Discussion and Analysis document are available on SEDAR.

OGI is pleased to report a profit this quarter of $119,695. Through Q3 they experienced exceptional sales and volume growth as the company further implemented both customer acquisition and retention strategies. Sales grew to $230,053 in Q3, representing an increase of 238% from the previous quarter. Grams sold during the period also experienced significant growth at 182%, for a total in excess of 31,000 grams.

The Company is on track to maintain this growth curve in Q4 with projected sales of $500,000 and in excess of 1,000 registered patients. As a result of the continued sales growth, the Company has completed four additional, 80 light, flowering rooms. It is anticipated that these new...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.